Intravitreal Injection of Bevacizumab (Avastin) to Treat Posterior Capsule Neovascularization

نویسندگان
doi
چکیده

We report a 64-year-old diabetic woman who developed neovascularization of the posterior capsule 2 years after cataract surgery and intraocular lens implantation. The patient was treated with single injection of 1.25 mg of intravitreal bevacizumab (Avastin) via pars plana. After one week, complete regression of the posterior capsule neovascularization was achieved allowing ...